Please note, this OEL/ADE monograph also applies to 6-Methyluracil (CAS RN 626-48- 2), 5 - Methyluracil (CAS RN 65-71-4), 1-Methyluracil (CAS RN 615-77-0), and 3-Methyluracil (CAS RN 608-34-4). Uracil is a pyrimidine nitrogenous base (2,4-dioxypyrimidine), which is the essential part of the ribonucleic acid (RNA) nucleotide. Among the minor nitrogen bases, methyluracil is used in medical practice for its improvement of tissue metabolism and regeneration, its anabolic and anticatabolic effects, and its ability to activate leucopoiesis. Methyluracil is indicated for the treatment of proctitis, sigmoiditis, and ulcerative colitis. It is also indicated topically as an anti-inflammatory and immunostimulating drug that improves trophic tissues and stimulates regeneration. Methyluracil is also investigated as an anabolic immunomodulator and as an antiphlogistic in experimental diabetes in rats. Antiviral and antitumor activities are the two most widely reported activities of uracil analogues.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value, the acceptable surface limit (ASL), and the Permitted Daily Exposure (PDE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Methyluracil, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.